Position in INBX
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$1,573,987
New position
Shares Held
16,612
first reported quarter
Ownership
0.113%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#60
of 162 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ratan Capital Management LP holds $2,269,164 across 2 Biotechnology names. INBX ranks #1 (69.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
This page
|
16,612 | $1,573,987 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
70,792 | $695,177 |
All Filings in INBX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,573,987 | 16,612 | Shares | Sole | 2026-08-18 | |
| No filing history on record for this holder in this stock. | ||||||